Du Qiang Wang
Directeur/Bestuurslid bij NOVOPROTEIN SCIENTIFIC INC.
Profiel
Du Qiang Wang is currently the Director at Novoprotein Scientific (Shanghai), Inc. since 2020.
He is also the Board Secretary, Director & Deputy General Manager at Suzhou Novoprotein Scientific Co., Ltd.
since 2010.
Mr. Wang graduated from Fudan University in 2017.
Actieve functies van Du Qiang Wang
| Bedrijven | Functie | Begin |
|---|---|---|
| NOVOPROTEIN SCIENTIFIC INC. | Directeur/Bestuurslid | 15-04-2021 |
Novoprotein Scientific (Shanghai), Inc.
 Novoprotein Scientific (Shanghai), Inc. Internet RetailRetail Trade Novoprotein Scientific (Shanghai), Inc. is a high-tech enterprise specializing in protein technology. Novoprotein Scientific (Shanghai is based in Shanghai, CN, with R&D and production bases in other locations, including Heze. The Chinese company's main focus is on biopharmaceuticals, in vitro diagnosis, vaccine drugs, and basic research on life sciences. The private company offers solutions such as targets and factor proteins, restructuring antibodies, enzymes, and reagents, and provide related technical services. The company was founded in 2009, and the CEO is Hua Xing Zhu. | Directeur/Bestuurslid | 12-08-2020 |
Opleiding van Du Qiang Wang
| Fudan University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| NOVOPROTEIN SCIENTIFIC INC. | Commercial Services |
| Bedrijven in privébezit | 1 |
|---|---|
Novoprotein Scientific (Shanghai), Inc.
Novoprotein Scientific (Shanghai), Inc. Internet RetailRetail Trade Novoprotein Scientific (Shanghai), Inc. is a high-tech enterprise specializing in protein technology. Novoprotein Scientific (Shanghai is based in Shanghai, CN, with R&D and production bases in other locations, including Heze. The Chinese company's main focus is on biopharmaceuticals, in vitro diagnosis, vaccine drugs, and basic research on life sciences. The private company offers solutions such as targets and factor proteins, restructuring antibodies, enzymes, and reagents, and provide related technical services. The company was founded in 2009, and the CEO is Hua Xing Zhu. | Retail Trade |
